by Dan DeMarle | Oct 16, 2024 | ADHD, Attention Deficit Hyperactivity Disorder, Other Health Impairment
“Attention Deficit/Hyperactivity Disorder (ADHD) is one of the most prevalent neurodevelopmental disorders and can persist into adulthood in the majority of cases. ADHD is associated with deficits in cognitive functions, in particular executive functions such as...
by Dan DeMarle | Oct 12, 2024 | ADHD, Attention Deficit Hyperactivity Disorder, Medicine, Other Health Impairment
“The U.S. Food and Drug Administration has approved Tris Pharma’s once-daily Onyda XR (clonidine hydrochloride) as the first liquid, nonstimulant treatment for attention-deficit/hyperactivity disorder (ADHD). The once-a-day, extended-release, oral...
by Dan DeMarle | Oct 12, 2024 | ADHD, Attention Deficit Hyperactivity Disorder, Other Health Impairment
HealthDay News — Diagnoses of attention-deficit/hyperactivity disorder (ADHD) in U.S. children continue to increase, with approximately one in nine having ever received a diagnosis, according to a study published online May 23 in the Journal of Clinical Child &...
by Dan DeMarle | Sep 30, 2024 | ADHD, Attention Deficit Hyperactivity Disorder, Other Health Impairment
24-9-29 NCHS Data Brief Number 499 March 2024 – db499Download
by Dan DeMarle | Sep 23, 2024 | Headache/Migraine, Other Health Impairment
“Blurred vision. Shimmering lights. Blind spots. Zigzag lines. This is what migraine aura looks like. Migraine is a neurological disorder characterized by severe, even debilitating, pain on one side of the head, and can be accompanied by other symptoms such as...
by Dan DeMarle | Sep 4, 2024 | ADHD, Other Health Impairment
“A recent study published in Journal of Attention Disorders reveals that young people with attention-deficit/hyperactivity disorder (ADHD) experience significantly higher levels of loneliness than their peers, highlighting a critical aspect of the disorder that...
